An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored Study

计划入组 95 人 · 首次发布于 2012 年 4 月 30 日

An Open-Label Extension Study to Evaluate Long-Term Safety and Tolerability of RO7234292 (RG6042) in Huntington's Disease Participants Who Participated in Prior Roche and Genentech Sponsored Studies

计划入组 236 人 · 首次发布于 2019 年 2 月 15 日

A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study

计划入组 100 人 · 首次发布于 2023 年 5 月 17 日

Anti-NaPi3b antibody-drug conjugate(Genentech/Roche)

tyrosine phosphatase inhibitors (Roche)

Myxopyronins (Roche)

Genentech

United States

GENENTECH INC

United States

GENENTECH, INC.

United States

Roche Launches Innovation Center at Harvard's Enterprise Research Campus to Advance CVRM Research and AI Applications

Genentech and Roche Secure UPC Evidence Orders Against Organon's Pertuzumab Biosimilar

Genentech's Phase IIb Study of Prasinezumab in Early-Stage Parkinson's Disease Misses Primary Goal